Atrix Laboratories Inc has received approval in Switzerland to market Atridox (8.5 per cent doxycycline) in the Atrigel delivery system for periodontal disease. Atrix anticipates marketing Atridox ...
Atridox used to investigate link between heart disease and chronic periodontitis Study including Atridox to investigate possible heart attack link to periodontal disease: This new three-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results